IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Clearmind Medicine Inc (CMND)

CUSIP: 185053600 | NYSE | Healthcare · Biotechnology | Micro Cap | 7 institutional holders

Quarters

Q3 2026Q2 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/ARichard Abbe
with Iroquois Capital Management, LLC, Kimberly Page
346,66710.0%New 5%+ stakeJun 30, 2026No 13F filer matched
13G/ARichard Abbe

Institutional Holders — Q3 2026

UBS Group AG5,626
0.0% of portfolio›$4.5K
AdvisorShares Investments LLC1,436
0.0% of portfolio›$1.2K
Caitong International Asset Management Co., Ltd1
0.0% of portfolio›$1
StyleTurnoverLocationFiled
UBS Group AG
5,626$4.5K0.0%CoreMediumZurich, Switzerland2026-11-10
AdvisorShares Investments LLC
1,436$1.2K0.0%Deep ValueVery HighBethesda, MD2026-11-09
Caitong International Asset Management Co., Ltd
1$10.0%GrowthVery HighHong Kong, South Korea2026-10-29
346,667
10.0% of class · Jun 30, 2026New 5%+ stake
with Iroquois Capital Management, LLC, Kimberly Page
No 13F filer matched